Mmastodon BusinessMarkets first seen 14 h ago, last 1 h ago, peak #1
Kobayashi Pharmaceutical weighs takeover offer worth over ¥500 billion
Original: Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese maker at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer valued at more than ¥500 billion. The possible deal comes as the company continues to face fallout from the scandal, which damaged its reputation and finances.
Why now: A potential multi-billion-yen buyout of a scandal-hit company has major implications for its future and Japan's supplements industry.
Rank over time, top of the chart is #1. 9 snapshots from 11 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/18193